Показать сокращенную информацию
dc.contributor.author | Nazarov N. | |
dc.contributor.author | Vyshtakalyuk A. | |
dc.contributor.author | Zobov V. | |
dc.contributor.author | Semenov V. | |
dc.date.accessioned | 2022-02-09T20:32:40Z | |
dc.date.available | 2022-02-09T20:32:40Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 0094-243X | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/168891 | |
dc.description.abstract | The main purpose of the work is to study toxicological effect of new pyrimidine derivative, saltlike conjugate of the drug Xymedon with L-ascorbic acid. As a result, it was shown that when intravenous injection of L- ascorbate 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidine-2-one was performed for 90 days in experimental animals at doses of 10 mg / kg, 30 mg/kg and 50 mg / kg, no significant pathological changes in the general condition of animals were detected, significant physiological and anatomical and histological changes were not observed. According to the results of daily intravenous injections for 3 months, the drug was assigned to the 3rd class of low-toxic drugs. | |
dc.relation.ispartofseries | AIP Conference Proceedings | |
dc.title | The study of chronic toxicity of L-ascorbate 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidine-2-one | |
dc.type | Conference Proceeding | |
dc.relation.ispartofseries-volume | 2388 | |
dc.collection | Публикации сотрудников КФУ | |
dc.source.id | SCOPUS0094243X-2021-2388-SID85120423216 |